You need to enable JavaScript to run this app.
Janssen’s Korean facility cited for GMP violations
Regulatory News
Ferdous Al-Faruque
Biologics/ biosimilars/ vaccines
Regulatory Intelligence/Policy
United States
US Food and Drug Administration (FDA)
Warning letters